https://assets.capyfin.com/instruments/678fdc13234e27009c5d586b.png avatar
Aramark
🇺🇸 NYSE:ARMK
View Company
OverviewEarningsDividends
•
Dec 27, 2019

Aramark Q1 2020 Earnings Report

Aramark's Q1 2020 financial performance largely materialized as expected and reflected the early actions of strategies to unlock the economic potential of the business.

Key Takeaways

Aramark reported a slight decrease in revenue, but organic revenue grew across all segments. Operating income and EPS decreased due to the prior year divestiture of the Healthcare Technologies business, but adjusted EPS remained unchanged. The company refinanced debt to strengthen its balance sheet.

Revenue decreased by 0.3%, but organic revenue increased by 1.6% with growth across all segments.

Operating Income decreased by 32%, while Adjusted Operating Income (AOI) decreased by 2%.

EPS decreased by 42% to $0.57, while Adjusted EPS remained unchanged at $0.62.

The company refinanced $900 million in debt, strengthening the balance sheet and improving financial flexibility.

Total Revenue
$4.25B
Previous year: $4.27B
-0.3%
EPS
$0.62
Previous year: $0.63
-1.6%
Gross Profit
$485M
Previous year: $471M
+3.1%
Cash and Equivalents
$265M
Previous year: $250M
+5.9%
Free Cash Flow
-$405M
Total Assets
$14.3B
Previous year: $13.7B
+3.9%

Aramark

Aramark

Aramark Revenue by Segment

Forward Guidance

As these strategies are implemented, the Company maintains its near-term financial performance outlook for Fiscal 2020.

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Company Overview

Full financial data and analysis

View Aramark